Autolus Therapeutics plc Quarterly Assets, Current in USD from Q3 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Autolus Therapeutics plc quarterly Assets, Current history and growth rate from Q3 2017 to Q2 2024.
  • Autolus Therapeutics plc Assets, Current for the quarter ending June 30, 2024 was $759M, a 113% increase year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $759M +$403M +113% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $804M +$410M +104% Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $275M -$150M -35.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $308M +$96.1M +45.3% Sep 30, 2023 10-K 2024-03-21
Q2 2023 $355M +$96.4M +37.2% Jun 30, 2023 10-K 2024-03-21
Q1 2023 $394M +$84.4M +27.3% Mar 31, 2023 10-K 2024-03-21
Q4 2022 $426M +$78.8M +22.7% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $212M Sep 30, 2022 10-K 2024-03-21
Q2 2022 $259M Jun 30, 2022 10-K 2024-03-21
Q1 2022 $309M +$21.4M +7.43% Mar 31, 2022 10-K 2024-03-21
Q4 2021 $347M +$150M +76.1% Dec 31, 2021 20-F 2023-03-07
Q1 2021 $288M +$7.12M +2.53% Mar 31, 2021 6-K 2021-05-06
Q4 2020 $197M -$52.3M -21% Dec 31, 2020 20-F 2022-03-10
Q3 2020 $229M -$31.3M -12% Sep 30, 2020 6-K 2020-11-05
Q2 2020 $249M -$44M -15% Jun 30, 2020 6-K 2020-08-06
Q1 2020 $281M Mar 31, 2020 6-K 2020-05-07
Q4 2019 $249M +$16.3M +6.99% Dec 31, 2019 20-F 2021-03-04
Q3 2019 $260M +$905K +0.35% Sep 30, 2019 6-K 2019-11-07
Q2 2019 $293M Jun 30, 2019 6-K 2019-08-08
Q4 2018 $233M Dec 31, 2018 20-F 2020-03-03
Q3 2018 $259M +$117M +82% Sep 30, 2018 20-F 2019-02-25
Q3 2017 $142M Sep 30, 2017 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.